Perceptive Advisors - ENVVENO MEDICAL CORPORATION ownership

ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 18 filers reported holding ENVVENO MEDICAL CORPORATION in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ENVVENO MEDICAL CORPORATION
ValueSharesWeighting
Q3 2023$4,212,905
+75.0%
781,6150.0%0.14%
+101.4%
Q2 2023$2,407,374
-34.2%
781,6150.0%0.07%
-35.2%
Q1 2023$3,657,958
-8.2%
781,6150.0%0.11%
-3.6%
Q4 2022$3,986,236
-18.8%
781,6150.0%0.11%
-21.1%
Q3 2022$4,909,000
+66.2%
781,6150.0%0.14%
+52.7%
Q2 2022$2,954,000
-40.7%
781,6150.0%0.09%
-7.0%
Q1 2022$4,978,000
-51.7%
781,615
-50.0%
0.10%
+26.6%
Q4 2021$10,300,0001,563,2300.08%
Other shareholders
ENVVENO MEDICAL CORPORATION shareholders Q1 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 401,200$1,517,0002.12%
KINGDON CAPITAL MANAGEMENT, L.L.C. 219,180$829,0000.14%
Perceptive Advisors 781,615$2,954,0000.09%
ARTHUR M. COHEN & ASSOCIATES, LLC 24,000$91,0000.02%
UBS OCONNOR LLC 118,113$446,000,0000.01%
Sepio Capital, LP 10,800$41,0000.00%
WELLS FARGO & COMPANY/MN 2,049$8,0000.00%
NORTHERN TRUST CORP 13,906$53,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 81,723$308,0000.00%
View complete list of ENVVENO MEDICAL CORPORATION shareholders